vs
Acadia Healthcare Company, Inc.（ACHC）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.1倍（$906.4M vs $829.0M），Rollins, Inc.净利率更高（11.9% vs 0.5%，领先11.4%），Rollins, Inc.同比增速更快（10.2% vs 7.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs 0.8%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
ACHC vs ROL — 直观对比
营收规模更大
ROL
是对方的1.1倍
$829.0M
营收增速更快
ROL
高出2.7%
7.5%
净利率更高
ROL
高出11.4%
0.5%
两年增速更快
ACHC
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $906.4M |
| 净利润 | $4.5M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | — | 16.1% |
| 净利率 | 0.5% | 11.9% |
| 营收同比 | 7.5% | 10.2% |
| 净利润同比 | -50.8% | 2.5% |
| 每股收益（稀释后） | $0.05 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCROL
| Q1 26 | $829.0M | $906.4M | ||
| Q4 25 | $821.5M | $912.9M | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $999.5M | ||
| Q1 25 | $770.5M | $822.5M | ||
| Q4 24 | $774.2M | $832.2M | ||
| Q3 24 | $815.6M | $916.3M | ||
| Q2 24 | $796.0M | $891.9M |
净利润ACHCROL
| Q1 26 | $4.5M | $107.8M | ||
| Q4 25 | $-1.2B | $116.4M | ||
| Q3 25 | $36.2M | $163.5M | ||
| Q2 25 | $30.1M | $141.5M | ||
| Q1 25 | $8.4M | $105.2M | ||
| Q4 24 | $32.6M | $105.7M | ||
| Q3 24 | $68.1M | $136.9M | ||
| Q2 24 | $78.5M | $129.4M |
营业利润率ACHCROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -142.4% | 17.5% | ||
| Q3 25 | 4.7% | 21.9% | ||
| Q2 25 | 5.8% | 19.8% | ||
| Q1 25 | 1.7% | 17.3% | ||
| Q4 24 | 4.9% | 18.1% | ||
| Q3 24 | 12.1% | 20.9% | ||
| Q2 24 | 13.4% | 20.4% |
净利率ACHCROL
| Q1 26 | 0.5% | 11.9% | ||
| Q4 25 | -143.3% | 12.8% | ||
| Q3 25 | 4.3% | 15.9% | ||
| Q2 25 | 3.5% | 14.2% | ||
| Q1 25 | 1.1% | 12.8% | ||
| Q4 24 | 4.2% | 12.7% | ||
| Q3 24 | 8.4% | 14.9% | ||
| Q2 24 | 9.9% | 14.5% |
每股收益（稀释后）ACHCROL
| Q1 26 | $0.05 | $0.22 | ||
| Q4 25 | $-12.98 | $0.24 | ||
| Q3 25 | $0.40 | $0.34 | ||
| Q2 25 | $0.33 | $0.29 | ||
| Q1 25 | $0.09 | $0.22 | ||
| Q4 24 | $0.36 | $0.22 | ||
| Q3 24 | $0.74 | $0.28 | ||
| Q2 24 | $0.85 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $116.5M |
| 总债务越低越好 | $2.5B | $650.6M |
| 股东权益账面价值 | $2.0B | $1.4B |
| 总资产 | $5.5B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资ACHCROL
| Q1 26 | $158.5M | $116.5M | ||
| Q4 25 | $133.2M | $100.0M | ||
| Q3 25 | $118.7M | $127.4M | ||
| Q2 25 | $131.4M | $123.0M | ||
| Q1 25 | $91.2M | $201.2M | ||
| Q4 24 | $76.3M | $89.6M | ||
| Q3 24 | $82.1M | $95.3M | ||
| Q2 24 | $77.2M | $106.7M |
总债务ACHCROL
| Q1 26 | $2.5B | $650.6M | ||
| Q4 25 | $2.5B | $486.1M | ||
| Q3 25 | $2.3B | $485.7M | ||
| Q2 25 | $2.3B | $485.3M | ||
| Q1 25 | $2.2B | $485.5M | ||
| Q4 24 | $2.0B | $395.3M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCROL
| Q1 26 | $2.0B | $1.4B | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $3.1B | $1.5B | ||
| Q2 25 | $3.1B | $1.4B | ||
| Q1 25 | $3.0B | $1.4B | ||
| Q4 24 | $3.1B | $1.3B | ||
| Q3 24 | $3.0B | $1.3B | ||
| Q2 24 | $3.0B | $1.2B |
总资产ACHCROL
| Q1 26 | $5.5B | $3.2B | ||
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | $6.4B | $3.2B | ||
| Q2 25 | $6.3B | $3.2B | ||
| Q1 25 | $6.1B | $2.9B | ||
| Q4 24 | $6.0B | $2.8B | ||
| Q3 24 | $5.9B | $2.8B | ||
| Q2 24 | $5.7B | $2.8B |
负债/权益比ACHCROL
| Q1 26 | 1.29× | 0.47× | ||
| Q4 25 | 1.28× | 0.35× | ||
| Q3 25 | 0.74× | 0.32× | ||
| Q2 25 | 0.74× | 0.34× | ||
| Q1 25 | 0.72× | 0.36× | ||
| Q4 24 | 0.64× | 0.30× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | 13.78× | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流ACHCROL
| Q1 26 | $61.5M | $118.4M | ||
| Q4 25 | $-86.3M | $164.7M | ||
| Q3 25 | $73.2M | $191.3M | ||
| Q2 25 | $133.5M | $175.1M | ||
| Q1 25 | $11.5M | $146.9M | ||
| Q4 24 | $116.7M | $188.2M | ||
| Q3 24 | $163.1M | $146.9M | ||
| Q2 24 | $171.1M | $145.1M |
自由现金流ACHCROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $-179.5M | $159.0M | ||
| Q3 25 | $-63.0M | $182.8M | ||
| Q2 25 | $-34.2M | $168.0M | ||
| Q1 25 | $-163.2M | $140.1M | ||
| Q4 24 | $-86.8M | $184.0M | ||
| Q3 24 | $-27.1M | $139.4M | ||
| Q2 24 | $16.9M | $136.4M |
自由现金流率ACHCROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | -21.8% | 17.4% | ||
| Q3 25 | -7.4% | 17.8% | ||
| Q2 25 | -3.9% | 16.8% | ||
| Q1 25 | -21.2% | 17.0% | ||
| Q4 24 | -11.2% | 22.1% | ||
| Q3 24 | -3.3% | 15.2% | ||
| Q2 24 | 2.1% | 15.3% |
资本支出强度ACHCROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 11.3% | 0.6% | ||
| Q3 25 | 16.0% | 0.8% | ||
| Q2 25 | 19.3% | 0.7% | ||
| Q1 25 | 22.7% | 0.8% | ||
| Q4 24 | 26.3% | 0.5% | ||
| Q3 24 | 23.3% | 0.8% | ||
| Q2 24 | 19.4% | 1.0% |
现金转化率ACHCROL
| Q1 26 | 13.78× | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | 2.02× | 1.17× | ||
| Q2 25 | 4.43× | 1.24× | ||
| Q1 25 | 1.37× | 1.40× | ||
| Q4 24 | 3.58× | 1.78× | ||
| Q3 24 | 2.39× | 1.07× | ||
| Q2 24 | 2.18× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ROL
暂无分部数据
